Literature DB >> 390050

A novel technique for detecting IgA coated potentially pathogenic microorganisms in the human intestine.

H K Van Saene, D Van der Waaij.   

Abstract

This paper describes a novel method for detecting immunoglobulin A (IgA) coated potentially pathogenic microorganisms (PPMs) in the human intestine. Essentially, the technique consists of 2 phases: one in which IgA coated bacteria are detected by immunofluorescence and a second in which these bacteria are subcultured in situ and subsequently identified. In this way transient bacteria are differentiated from resident bacteria. These results show that the resident bacteria are coated with IgA. Resident microorganisms are always highly concentrated in the digestive tract. These results strengthen the hypothesis that only the high antigen concentrations achieved by a large number of resident bacteria are capable of IgA induction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 390050     DOI: 10.1016/0022-1759(79)90276-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Decreased expression of mannose-specific adhesins by Escherichia coli in the colonic microflora of immunoglobulin A-deficient individuals.

Authors:  V Friman; I Adlerberth; H Connell; C Svanborg; L A Hanson; A E Wold
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  The effect of glucocorticoid administration on bacterial translocation. Evidence for an acquired mucosal immunodeficient state.

Authors:  J Alverdy; E Aoys
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

3.  No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice.

Authors:  H Marcotte; M C Lavoie
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.

Authors:  K E Shroff; K Meslin; J J Cebra
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.